Max Plischke

768 total citations
17 papers, 579 citations indexed

About

Max Plischke is a scholar working on Nephrology, Transplantation and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Max Plischke has authored 17 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 6 papers in Transplantation and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Max Plischke's work include Renal Transplantation Outcomes and Treatments (6 papers), Dialysis and Renal Disease Management (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Max Plischke is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Dialysis and Renal Disease Management (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Max Plischke collaborates with scholars based in Austria, United States and Germany. Max Plischke's co-authors include Georg Heinze, Karen Leffondré, Daniela Dunkler, Maria Kohl, Martin Haas, Daniel Cejka, Rodrig Marculescu, Nicolas Kozakowski, Thomas Reiter and Alois Gessl and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and European Heart Journal.

In The Last Decade

Max Plischke

17 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Plischke Austria 9 209 101 90 86 82 17 579
Euy Jin Choi South Korea 16 411 2.0× 109 1.1× 88 1.0× 79 0.9× 93 1.1× 45 792
Serhan Tuğlular Türkiye 17 300 1.4× 75 0.7× 123 1.4× 150 1.7× 230 2.8× 96 986
Mark Rutkowski United States 14 303 1.4× 55 0.5× 87 1.0× 109 1.3× 57 0.7× 18 561
Antoine Bouquegneau Belgium 14 229 1.1× 63 0.6× 127 1.4× 43 0.5× 87 1.1× 38 563
Kenan Ateş Türkiye 13 269 1.3× 50 0.5× 50 0.6× 152 1.8× 109 1.3× 54 708
Monica Simonetti Italy 12 250 1.2× 65 0.6× 48 0.5× 82 1.0× 146 1.8× 32 673
Vinod Krishnappa United States 17 337 1.6× 61 0.6× 94 1.0× 98 1.1× 106 1.3× 38 761
Allison A. Venner Canada 15 97 0.5× 66 0.7× 96 1.1× 95 1.1× 133 1.6× 40 804
Kuanrong Li China 10 49 0.2× 48 0.5× 96 1.1× 49 0.6× 57 0.7× 37 658

Countries citing papers authored by Max Plischke

Since Specialization
Citations

This map shows the geographic impact of Max Plischke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Plischke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Plischke more than expected).

Fields of papers citing papers by Max Plischke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Plischke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Plischke. The network helps show where Max Plischke may publish in the future.

Co-authorship network of co-authors of Max Plischke

This figure shows the co-authorship network connecting the top 25 collaborators of Max Plischke. A scholar is included among the top collaborators of Max Plischke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Plischke. Max Plischke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Plischke, Max, et al.. (2016). The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients. Clinical Laboratory. 62(10/2016). 1965–1972. 6 indexed citations
3.
Bankir, Lise, Max Plischke, Nadine Bouby, & Martin Haas. (2015). Urine Osmolarity and Risk of Dialysis Initiation in a CKD Cohort. Annals of Nutrition and Metabolism. 66(Suppl. 3). 14–17. 5 indexed citations
4.
Plischke, Max, Daniela Dunkler, Georg Heinze, et al.. (2015). Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. PLoS ONE. 10(8). e0135674–e0135674. 2 indexed citations
5.
Bielesz, Bernhard, Manfred Hecking, Max Plischke, et al.. (2014). Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients. Clinical Biochemistry. 47(13-14). 1316–1319. 7 indexed citations
6.
Kohl, Maria, Max Plischke, Karen Leffondré, & Georg Heinze. (2014). PSHREG: A SAS macro for proportional and nonproportional subdistribution hazards regression. Computer Methods and Programs in Biomedicine. 118(2). 218–233. 110 indexed citations
7.
Plischke, Max, Maria Kohl, Lise Bankir, et al.. (2014). Urine Osmolarity and Risk of Dialysis Initiation in a Chronic Kidney Disease Cohort – a Possible Titration Target?. PLoS ONE. 9(3). e93226–e93226. 28 indexed citations
8.
Dunkler, Daniela, Max Plischke, Karen Leffondré, & Georg Heinze. (2014). Augmented Backward Elimination: A Pragmatic and Purposeful Way to Develop Statistical Models. PLoS ONE. 9(11). e113677–e113677. 132 indexed citations
9.
Plischke, Max, Stephanie Neuhold, Maria Kohl, et al.. (2013). Renal Function in Heart Failure: A Disparity between Estimating Function and Predicting Mortality Risk. European Journal of Heart Failure. 15(7). 763–770. 16 indexed citations
10.
Plischke, Max, Sabine Steiner, Daniela Seidinger, et al.. (2013). Effect of Conversion From Ciclosporin to Tacrolimus on Endothelial Progenitor Cells in Stable Long-Term Kidney Transplant Recipients. Transplantation. 95(11). 1338–1345. 5 indexed citations
11.
Cejka, Daniel, Rodrig Marculescu, Nicolas Kozakowski, et al.. (2013). Renal Elimination of Sclerostin Increases With Declining Kidney Function. The Journal of Clinical Endocrinology & Metabolism. 99(1). 248–255. 105 indexed citations
13.
Kikić, Željko, Harald Herkner, Gürkan Sengölge, et al.. (2013). Pretransplant risk stratification for early survival of renal allograft recipients. European Journal of Clinical Investigation. 44(2). 168–175. 6 indexed citations
14.
Hecking, Manfred, Alexander Kainz, Bernhard Bielesz, et al.. (2012). Clinical evaluation of two novel biointact PTH(1–84) assays in hemodialysis patients. Clinical Biochemistry. 45(18). 1645–1651. 14 indexed citations
15.
Goliasch, Georg, Marcus E. Kleber, Bernhard Richter, et al.. (2012). Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. European Heart Journal. 33(18). 2282–2289. 46 indexed citations
16.
Plischke, Max, et al.. (2012). Knowledge-Based Tacrolimus Therapy for Kidney Transplant Patients. Studies in health technology and informatics. 180. 310–4. 6 indexed citations
17.
Plischke, Max, Stephanie Neuhold, Christopher Adlbrecht, et al.. (2011). Inorganic phosphate and FGF‐23 predict outcome in stable systolic heart failure. European Journal of Clinical Investigation. 42(6). 649–656. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026